by Emily Kopp, Sydney Lupkin, and Elizabeth Lucas, Kaiser Health News. Pharmaceutical companies gave at least $116 million to patient advocacy groups in a single year, reveals a new database logging 12,000 donations from large publicly traded drugmakers to such organizations..